Shares Outstanding Shares Outstanding n/a Close	225.94M
Shares Change (YoY) Shares Change (YoY) n/a Close	-2.18%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-1.97%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	88.47%
Shares Floating Shares Floating n/a Close	225.55M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	718
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.04%

Short Selling Information

The latest short interest is 2.2M, so 0.97% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	2.2M
Short % of Shares Out Short % of Shares Out n/a Close	0.97%
Short % of Float Short % of Float n/a Close	0.97%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1.1

Valuation Ratios

The PE ratio is 14.37 and the forward PE ratio is 9.82. Elevance Health's PEG ratio is 6.15.

PE Ratio PE Ratio n/a Close	14.37
Forward PE Forward PE n/a Close	9.82
PS Ratio PS Ratio n/a Close	0.49
Forward PS Forward PS n/a Close	0.3
PB Ratio PB Ratio n/a Close	2.08
P/FCF Ratio P/FCF Ratio n/a Close	18.87
PEG Ratio PEG Ratio n/a Close	6.15

Financial Ratio History

Enterprise Valuation

Elevance Health has an Enterprise Value (EV) of 108.85B.

EV / Sales EV / Sales n/a Close	0.62
EV / EBITDA EV / EBITDA n/a Close	11.98
EV / EBIT EV / EBIT n/a Close	18.74
EV / FCF EV / FCF n/a Close	23.91

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.76.

Current Ratio Current Ratio n/a Close	2.01
Quick Ratio Quick Ratio n/a Close	2.01
Debt / Equity Debt / Equity n/a Close	0.76
Debt / EBITDA Debt / EBITDA n/a Close	3.44
Debt / FCF Debt / FCF n/a Close	6.86
Interest Coverage Interest Coverage n/a Close	6.67

Financial Efficiency

Return on Equity is 14.47% and Return on Invested Capital is 6.44%.

Return on Equity Return on Equity n/a Close	14.47%
Return on Assets Return on Assets n/a Close	5.12%
Return on Invested Capital Return on Invested Capital n/a Close	6.44%
Revenue Per Employee Revenue Per Employee n/a Close	$1,696,833.01
Profits Per Employee Profits Per Employee n/a Close	$57,389.64
Employee Count Employee Count n/a Close	104,200
Asset Turnover Asset Turnover n/a Close	1.51
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	1.93B
Effective Tax Rate Effective Tax Rate n/a Close	24.46%

Stock Price Statistics

The stock price has increased by -29.54% in the last 52 weeks. The beta is 0.62, so Elevance Health's price volatility has been higher than the market average.

Beta Beta n/a Close	0.62
52-Week Price Change 52-Week Price Change n/a Close	-29.54%
50-Day Moving Average 50-Day Moving Average n/a Close	404.63
200-Day Moving Average 200-Day Moving Average n/a Close	424.29
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	41.41
Average Volume (20 Days) Average Volume (20 Days) n/a Close	1,774,611

Income Statement

In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 26.29.

Revenue Revenue n/a Close	176.81B
Gross Profit Gross Profit n/a Close	157.26B
Operating Income Operating Income n/a Close	7.9B
Net Income Net Income n/a Close	5.98B
EBITDA EBITDA n/a Close	9.09B
EBIT EBIT n/a Close	9.09B
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	26.29

Full Income Statement

Balance Sheet

The company has 8.29B in cash and 31.23B in debt, giving a net cash position of -22.94B.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	8.29B
Total Debt Total Debt n/a Close	31.23B
Net Cash Net Cash n/a Close	-22.94B
Retained Earnings Retained Earnings n/a Close	33.55B
Total Assets Total Assets n/a Close	119.72B
Working Capital Working Capital n/a Close	18.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.81B and capital expenditures -1.26B, giving a free cash flow of 4.55B.

Operating Cash Flow Operating Cash Flow n/a Close	5.81B
Capital Expenditures Capital Expenditures n/a Close	-1.26B
Free Cash Flow Free Cash Flow n/a Close	4.55B
FCF Per Share FCF Per Share n/a Close	19.55

Full Cash Flow Statement

Margins

Gross margin is 88.94%, with operating and profit margins of 4.47% and 3.38%.

Gross Margin Gross Margin n/a Close	88.94%
Operating Margin Operating Margin n/a Close	4.47%
Pretax Margin Pretax Margin n/a Close	4.47%
Profit Margin Profit Margin n/a Close	3.38%
EBITDA Margin EBITDA Margin n/a Close	5.14%
EBIT Margin EBIT Margin n/a Close	4.47%
FCF Margin FCF Margin n/a Close	2.57%

Dividends & Yields

ELV pays an annual dividend of $8.31, which amounts to a dividend yield of 1.74%.

Dividend Per Share Dividend Per Share n/a Close	$8.31
Dividend Yield Dividend Yield n/a Close	1.74%
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	4.91%
Payout Ratio Payout Ratio n/a Close	32.32%
Earnings Yield Earnings Yield n/a Close	6.96%
FCF Yield FCF Yield n/a Close	5.3%

Dividend Details

Analyst Forecast

The average price target for ELV is $502.5, which is 33.5% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$502.5
Price Target Difference Price Target Difference n/a Close	33.5%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	14

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$199.8
Lynch Upside Lynch Upside n/a Close	-46.93%
Graham Number Graham Number n/a Close	320.18
Graham Upside Graham Upside n/a Close	-14.96%

Stock Splits

The last stock split was on Jun 1, 2005. It was a forward split with a ratio of 2:1.

Last Split Date Last Split Date n/a Close	Jun 1, 2005
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	2:1

Scores

Altman Z-Score Altman Z-Score n/a Close	3.03
Piotroski F-Score Piotroski F-Score n/a Close	7